Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure with Preserved Ejection Fraction: The TOPCAT Trial

BACKGROUND: Albuminuria predicts adverse events in heart failure with preserved ejection fraction (HFpEF). No therapies to date have reduced albuminuria in HFpEF. METHODS AND RESULTS: We analyzed 1175 participants from the Americas from the Treatment of Preserved Cardiac Function Heart Failure with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Circ Heart Fail
Autors principals: Selvaraj, Senthil, Claggett, Brian, Shah, Sanjiv J., Anand, Inder, Rouleau, Jean L., O’Meara, Eileen, Desai, Akshay S., Lewis, Eldrin F., Pitt, Bertram, Sweitzer, Nancy K., Fang, James C., Pfeffer, Marc A., Solomon, Scott D.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6594383/
https://ncbi.nlm.nih.gov/pubmed/30571191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005288
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars